1 Market Overview of Depression Drugs 1.1 Depression Drugs Market Overview 1.1.1 Depression Drugs Product Scope 1.1.2 Market Status and Outlook 1.2 Global Depression Drugs Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Depression Drugs Market Size by Region (2015-2026) 1.4 Global Depression Drugs Historic Market Size by Region (2015-2020) 1.5 Global Depression Drugs Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Depression Drugs Market Size YoY Growth (2015-2026) 1.6.1 North America Depression Drugs Market Size YoY Growth (2015-2026) 1.6.2 Europe Depression Drugs Market Size YoY Growth (2015-2026) 1.6.3 Asia-Pacific Depression Drugs Market Size YoY Growth (2015-2026) 1.6.4 Latin America Depression Drugs Market Size YoY Growth (2015-2026) 1.6.5 Middle East & Africa Depression Drugs Market Size YoY Growth (2015-2026) 2 Depression Drugs Market Overview by Type 2.1 Global Depression Drugs Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Depression Drugs Historic Market Size by Type (2015-2020) 2.3 Global Depression Drugs Forecasted Market Size by Type (2021-2026) 2.4 SSRIs 2.5 SNRIs 2.6 Others 3 Depression Drugs Market Overview by Application 3.1 Global Depression Drugs Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Depression Drugs Historic Market Size by Application (2015-2020) 3.3 Global Depression Drugs Forecasted Market Size by Application (2021-2026) 3.4 Hospitals 3.5 Clinics 3.6 Others 4 Global Depression Drugs Competition Analysis by Players 4.1 Global Depression Drugs Market Size (Million US$) by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Depression Drugs as of 2019) 4.3 Date of Key Manufacturers Enter into Depression Drugs Market 4.4 Global Top Players Depression Drugs Headquarters and Area Served 4.5 Key Players Depression Drugs Product Solution and Service 4.6 Competitive Status 4.6.1 Depression Drugs Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Intellipharmaceutics 5.1.1 Intellipharmaceutics Profile 5.1.2 Intellipharmaceutics Main Business 5.1.3 Intellipharmaceutics Products, Services and Solutions 5.1.4 Intellipharmaceutics Revenue (US$ Million) & (2015-2020) 5.1.5 Intellipharmaceutics Recent Developments 5.2 Pfizer 5.2.1 Pfizer Profile 5.2.2 Pfizer Main Business and Company’s Total Revenue 5.2.3 Pfizer Products, Services and Solutions 5.2.4 Pfizer Revenue (US$ Million) (2015-2020) 5.2.5 Pfizer Recent Development and Reaction to Covid-19 5.3 Eli Lilly 5.5.1 Eli Lilly Profile 5.3.2 Eli Lilly Main Business 5.3.3 Eli Lilly Products, Services and Solutions 5.3.4 Eli Lilly Revenue (US$ Million) & (2015-2020) 5.3.5 Astrazeneca Recent Developments 5.4 Astrazeneca 5.4.1 Astrazeneca Profile 5.4.2 Astrazeneca Main Business 5.4.3 Astrazeneca Products, Services and Solutions 5.4.4 Astrazeneca Revenue (US$ Million) & (2015-2020) 5.4.5 Astrazeneca Recent Developments 5.5 Lundbeck 5.5.1 Lundbeck Profile 5.5.2 Lundbeck Main Business 5.5.3 Lundbeck Products, Services and Solutions 5.5.4 Lundbeck Revenue (US$ Million) & (2015-2020) 5.5.5 Lundbeck Recent Developments 5.6 Allergan 5.6.1 Allergan Profile 5.6.2 Allergan Main Business 5.6.3 Allergan Products, Services and Solutions 5.6.4 Allergan Revenue (US$ Million) & (2015-2020) 5.6.5 Allergan Recent Developments 5.7 GSK 5.7.1 GSK Profile 5.7.2 GSK Main Business and Company’s Total Revenue 5.7.3 GSK Products, Services and Solutions 5.7.4 GSK Revenue (US$ Million) (2015-2020) 5.7.5 GSK Recent Development and Reaction to Covid-19 5.8 Otsuka Pharmaceutical 5.8.1 Otsuka Pharmaceutical Profile 5.8.2 Otsuka Pharmaceutical Main Business 5.8.3 Otsuka Pharmaceutical Products, Services and Solutions 5.8.4 Otsuka Pharmaceutical Revenue (US$ Million) & (2015-2020) 5.8.5 Otsuka Pharmaceutical Recent Developments 5.9 Takeda 5.9.1 Takeda Profile 5.9.2 Takeda Main Business 5.9.3 Takeda Products, Services and Solutions 5.9.4 Takeda Revenue (US$ Million) & (2015-2020) 5.9.5 Takeda Recent Developments 5.10 NHU Group 5.10.1 NHU Group Profile 5.10.2 NHU Group Main Business 5.10.3 NHU Group Products, Services and Solutions 5.10.4 NHU Group Revenue (US$ Million) & (2015-2020) 5.10.5 NHU Group Recent Developments 5.11 Shionogi 5.11.1 Shionogi Profile 5.11.2 Shionogi Main Business 5.11.3 Shionogi Products, Services and Solutions 5.11.4 Shionogi Revenue (US$ Million) & (2015-2020) 5.11.5 Shionogi Recent Developments 5.12 APOTEX 5.12.1 APOTEX Profile 5.12.2 APOTEX Main Business 5.12.3 APOTEX Products, Services and Solutions 5.12.4 APOTEX Revenue (US$ Million) & (2015-2020) 5.12.5 APOTEX Recent Developments 5.13 Kanghong Pharma 5.13.1 Kanghong Pharma Profile 5.13.2 Kanghong Pharma Main Business 5.13.3 Kanghong Pharma Products, Services and Solutions 5.13.4 Kanghong Pharma Revenue (US$ Million) & (2015-2020) 5.13.5 Kanghong Pharma Recent Developments 5.14 HUAHAI 5.14.1 HUAHAI Profile 5.14.2 HUAHAI Main Business 5.14.3 HUAHAI Products, Services and Solutions 5.14.4 HUAHAI Revenue (US$ Million) & (2015-2020) 5.14.5 HUAHAI Recent Developments 6 North America 6.1 North America Depression Drugs Market Size by Country 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Depression Drugs Market Size by Country 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Depression Drugs Market Size by Region 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Depression Drugs Market Size by Country 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Depression Drugs Market Size by Country 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Depression Drugs Market Dynamics 11.1 Industry Trends 11.2 Market Drivers 11.3 Market Challenges 11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Depression Drugs Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Depression Drugs Market Size by Region (2015-2020) (US$ Million) Table 3. Global Depression Drugs Market Size Share by Region (2015-2020) Table 4. Global Depression Drugs Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Depression Drugs Forecasted Market Size Share by Region (2021-2026) Table 6. Global Depression Drugs Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Depression Drugs Market Size by Type (2015-2020) (US$ Million) Table 8. Global Depression Drugs Revenue Market Share by Type (2015-2020) Table 9. Global Depression Drugs Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Depression Drugs Revenue Market Share by Type (2021-2026) Table 11. Global Depression Drugs Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Depression Drugs Market Size by Application (2015-2020) (US$ Million) Table 13. Global Depression Drugs Revenue Market Share by Application (2015-2020) Table 14. Global Depression Drugs Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Depression Drugs Revenue Market Share by Application (2021-2026) Table 16. Global Depression Drugs Revenue (US$ Million) by Players (2015-2020) Table 17. Global Depression Drugs Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Depression Drugs as of 2019) Table 19. Date of Key Manufacturers Enter into Depression Drugs Market Table 20. Global Depression Drugs Top Players Headquarters and Area Served Table 21. Depression Drugs Product Solution and Service Table 22. Global Depression Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Intellipharmaceutics Basic Information List Table 25. Intellipharmaceutics Description and Business Overview Table 26. Intellipharmaceutics Depression Drugs Products, Services and Solutions Table 27. Revenue (Million US$) in Depression Drugs Business of Intellipharmaceutics (2015-2020) Table 28. Intellipharmaceutics Recent Developments Table 29. Pfizer Basic Information List Table 30. Pfizer Description and Business Overview Table 31. Pfizer Depression Drugs Products, Services and Solutions Table 32. Revenue (Million US$) in Depression Drugs Business of Pfizer (2015-2020) Table 33. Pfizer Recent Developments Table 34. Eli Lilly Basic Information List Table 35. Eli Lilly Description and Business Overview Table 36. Eli Lilly Depression Drugs Products, Services and Solutions Table 37. Revenue (Million US$) in Depression Drugs Business of Eli Lilly (2015-2020) Table 38. Eli Lilly Recent Developments Table 39. Astrazeneca Basic Information List Table 40. Astrazeneca Description and Business Overview Table 41. Astrazeneca Depression Drugs Products, Services and Solutions Table 42. Revenue (Million US$) in Depression Drugs Business of Astrazeneca (2015-2020) Table 43. Astrazeneca Recent Developments Table 44. Lundbeck Basic Information List Table 45. Lundbeck Description and Business Overview Table 46. Lundbeck Depression Drugs Products, Services and Solutions Table 47. Revenue (Million US$) in Depression Drugs Business of Lundbeck (2015-2020) Table 48. Lundbeck Recent Developments Table 49. Allergan Basic Information List Table 50. Allergan Description and Business Overview Table 51. Allergan Depression Drugs Products, Services and Solutions Table 52. Revenue (Million US$) in Depression Drugs Business of Allergan (2015-2020) Table 53. Allergan Recent Developments Table 54. GSK Basic Information List Table 55. GSK Description and Business Overview Table 56. GSK Depression Drugs Products, Services and Solutions Table 57. Revenue (Million US$) in Depression Drugs Business of GSK (2015-2020) Table 58. GSK Recent Developments Table 59. Otsuka Pharmaceutical Basic Information List Table 60. Otsuka Pharmaceutical Description and Business Overview Table 61. Otsuka Pharmaceutical Depression Drugs Products, Services and Solutions Table 62. Revenue (Million US$) in Depression Drugs Business of Otsuka Pharmaceutical (2015-2020) Table 63. Otsuka Pharmaceutical Recent Developments Table 64. Takeda Basic Information List Table 65. Takeda Description and Business Overview Table 66. Takeda Depression Drugs Products, Services and Solutions Table 67. Revenue (Million US$) in Depression Drugs Business of Takeda (2015-2020) Table 68. Takeda Recent Developments Table 69. NHU Group Basic Information List Table 70. NHU Group Description and Business Overview Table 71. NHU Group Depression Drugs Products, Services and Solutions Table 72. Revenue (Million US$) in Depression Drugs Business of NHU Group (2015-2020) Table 73. NHU Group Recent Developments Table 74. Shionogi Basic Information List Table 75. Shionogi Description and Business Overview Table 76. Shionogi Depression Drugs Products, Services and Solutions Table 77. Revenue (Million US$) in Depression Drugs Business of Shionogi (2015-2020) Table 78. Shionogi Recent Developments Table 79. APOTEX Basic Information List Table 80. APOTEX Description and Business Overview Table 81. APOTEX Depression Drugs Products, Services and Solutions Table 82. Revenue (Million US$) in Depression Drugs Business of APOTEX (2015-2020) Table 83. APOTEX Recent Developments Table 84. Kanghong Pharma Basic Information List Table 85. Kanghong Pharma Description and Business Overview Table 86. Kanghong Pharma Depression Drugs Products, Services and Solutions Table 87. Revenue (Million US$) in Depression Drugs Business of Kanghong Pharma (2015-2020) Table 88. Kanghong Pharma Recent Developments Table 89. HUAHAI Basic Information List Table 90. HUAHAI Description and Business Overview Table 91. HUAHAI Depression Drugs Products, Services and Solutions Table 92. Revenue (Million US$) in Depression Drugs Business of HUAHAI (2015-2020) Table 93. HUAHAI Recent Developments Table 94. North America Depression Drugs Market Size by Country (2015-2020) & (US$ Million) Table 95. North America Depression Drugs Market Size Share by Country (2015-2020) Table 96. Europe Depression Drugs Market Size by Country (2015-2020) & (US$ Million) Table 97. Europe Depression Drugs Market Size Share by Country (2015-2020) Table 98. Asia-Pacific Depression Drugs Market Size by Country (2015-2020) & (US$ Million) Table 99. Asia-Pacific Depression Drugs Market Size Share by Country (2015-2020) (US$ Million) Table 100. Latin America Depression Drugs Market Size by Country (2015-2020) & (US$ Million) Table 101. Latin America Depression Drugs Market Size Share by Country (2015-2020) (US$ Million) Table 102. Middle East & Africa Depression Drugs Market Size by Players (2015-2020) (US$ Million) Table 103. Middle East & Africa Depression Drugs Market Size Share by Players (2015-2020) (US$ Million) Table 104. Depression Drugs Market Trends Table 105. Depression Drugs Market Drivers Table 106. Depression Drugs Market Challenges Table 107. Depression Drugs Market Restriants Table 108. Research Programs/Design for This Report Table 109. Key Data Information from Secondary Sources Table 110. Key Data Information from Primary Sources List of Figures Figure 1. Global Depression Drugs Market Size Year-over-Year 2015-2026 & (US$ Million) Figure 2. Global Depression Drugs Market Size (US$ Million), 2015 VS 2020VS 2026 Figure 3. Global Depression Drugs Market Share by Regions: 2020 VS 2026 Figure 4. North America Depression Drugs Market Size (US$ Million) Growth Rate (2015-2026) Figure 5. Europe Depression Drugs Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Asia-Pacific Depression Drugs Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Depression Drugs Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Depression Drugs Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Depression Drugs Market Share by Type in 2020 & 2026 Figure 10. SSRIs Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. SNRIs Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. Others Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Global Depression Drugs Market Size Share by Application in 2020 & 2026 Figure 14. Hospitals Market Size (US$ Million) YoY Growth (2015-2026) Figure 15. Clinics Market Size (US$ Million) YoY Growth (2015-2026) Figure 16. Others Market Size (US$ Million) YoY Growth (2015-2026) Figure 17. Depression Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global Top 5 and Top 10 Players Depression Drugs Market Share in 2019 Figure 19. United States Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Canada Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Germany Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. France Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. U.K. Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Italy Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Russia Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Nordic Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Rest of Europe Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. China Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Japan Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. South Korea Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Southeast Asia Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. India Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Australia Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Rest of Asia-Pacific Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Mexico Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Brazil Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Rest of Latin America Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Turkey Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Saudi Arabia Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. UAE Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Rest of Middle East & Africa Depression Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Bottom-up and Top-down Approaches for This Report Figure 43. Data Triangulation

Intellipharmaceutics Pfizer Eli Lilly Astrazeneca Lundbeck Allergan GSK Otsuka Pharmaceutical Takeda NHU Group Shionogi APOTEX Kanghong Pharma HUAHAI